206 related articles for article (PubMed ID: 14675584)
1. A propensity score-matched cohort study of the effect of statins, mainly fluvastatin, on the occurrence of acute myocardial infarction.
Seeger JD; Walker AM; Williams PL; Saperia GM; Sacks FM
Am J Cardiol; 2003 Dec; 92(12):1447-51. PubMed ID: 14675584
[TBL] [Abstract][Full Text] [Related]
2. Effect of fluvastatin on ischaemia following acute myocardial infarction: a randomized trial.
Liem AH; van Boven AJ; Veeger NJ; Withagen AJ; Robles de Medina RM; Tijssen JG; van Veldhuisen DJ;
Eur Heart J; 2002 Dec; 23(24):1931-7. PubMed ID: 12473255
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness of statins for secondary prevention in elderly patients after acute myocardial infarction: an evaluation of class effect.
Zhou Z; Rahme E; Abrahamowicz M; Tu JV; Eisenberg MJ; Humphries K; Austin PC; Pilote L
CMAJ; 2005 Apr; 172(9):1187-94. PubMed ID: 15851712
[TBL] [Abstract][Full Text] [Related]
4. Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice.
Harley CR; Gandhi S; Blasetto J; Heien H; Sasane R; Nelson SP
Am J Geriatr Pharmacother; 2007 Sep; 5(3):185-94. PubMed ID: 17996658
[TBL] [Abstract][Full Text] [Related]
5. Which statin is most efficient for the treatment of hypercholesterolemia? A cost-effectiveness analysis.
Cobos A; Jovell AJ; García-Altés A; García-Closas R; Serra-Majem L
Clin Ther; 1999 Nov; 21(11):1924-36. PubMed ID: 10890264
[TBL] [Abstract][Full Text] [Related]
6. Hydroxymethylglutaryl-CoA reductase inhibitors in older persons with acute myocardial infarction: evidence for an age-statin interaction.
Foody JM; Rathore SS; Galusha D; Masoudi FA; Havranek EP; Radford MJ; Krumholz HM
J Am Geriatr Soc; 2006 Mar; 54(3):421-30. PubMed ID: 16551308
[TBL] [Abstract][Full Text] [Related]
7. Effects of fluvastatin, an HMG-CoA reductase inhibitor, on serum levels of interleukin-18 and matrix metalloproteinase-9 in patients with hypercholesterolemia.
Leu HB; Chen JW; Wu TC; Ding YA; Lin SJ; Charng MJ
Clin Cardiol; 2005 Sep; 28(9):423-8. PubMed ID: 16250265
[TBL] [Abstract][Full Text] [Related]
8. Effect of fluvastatin on intermediate density lipoprotein (remnants) and other lipoprotein levels in hypercholesterolemia.
Broyles FE; Walden CE; Hunninghake DB; Hill-Williams D; Knopp RH
Am J Cardiol; 1995 Jul; 76(2):129A-135A. PubMed ID: 7604788
[TBL] [Abstract][Full Text] [Related]
9. Fluvastatin: efficacy and safety in reducing cardiac events.
Chan MY; Lee CH
Expert Opin Pharmacother; 2005 Sep; 6(11):1883-95. PubMed ID: 16144508
[TBL] [Abstract][Full Text] [Related]
10. A randomized placebo-controlled trial of fluvastatin for prevention of restenosis after successful coronary balloon angioplasty; final results of the fluvastatin angiographic restenosis (FLARE) trial.
Serruys PW; Foley DP; Jackson G; Bonnier H; Macaya C; Vrolix M; Branzi A; Shepherd J; Suryapranata H; de Feyter PJ; Melkert R; van Es GA; Pfister PJ
Eur Heart J; 1999 Jan; 20(1):58-69. PubMed ID: 10075142
[TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness analysis of cholesterol-lowering therapies in Spain.
Plans-Rubió P
Am J Cardiovasc Drugs; 2006; 6(3):177-88. PubMed ID: 16780391
[TBL] [Abstract][Full Text] [Related]
12. Effect of fluvastatin on acute renal allograft rejection: a randomized multicenter trial.
Holdaas H; Jardine AG; Wheeler DC; Brekke IB; Conlon PJ; Fellstrøm B; Hammad A; Holme I; Isoniemi H; Moore R; Rowe PA; Sweny P; Talbot DA; Wadstrøm J; Østraat Ø
Kidney Int; 2001 Nov; 60(5):1990-7. PubMed ID: 11703619
[TBL] [Abstract][Full Text] [Related]
13. Newer HMG-CoA reductase inhibitor (statin) therapies.
Brinton EA
Clin Cardiol; 2001; 24(7 Suppl):II-10-3. PubMed ID: 11444648
[TBL] [Abstract][Full Text] [Related]
14. Effect of combined fluvastatin-fenofibrate therapy compared with fenofibrate monotherapy in severe primary hypercholesterolemia. French Fluvastatin Study Group.
Farnier M; Dejager S
Am J Cardiol; 2000 Jan; 85(1):53-7. PubMed ID: 11078237
[TBL] [Abstract][Full Text] [Related]
15. [Not just decreased LDL level is decisive. Which statin for patients at risk for coronary disease?].
MMW Fortschr Med; 2004 Jun; 146(24):1-3. PubMed ID: 15366507
[No Abstract] [Full Text] [Related]
16. A comparative crossover study of the effects of fluvastatin and pravastatin (FP-COS) on circulating autoantibodies to oxidized LDL in patients with hypercholesterolemia.
Zhang B; Noda K; Matsunaga A; Kumagai K; Saku K
J Atheroscler Thromb; 2005; 12(1):41-7. PubMed ID: 15725695
[TBL] [Abstract][Full Text] [Related]
17. Improvement of myocardial perfusion by short-term fluvastatin therapy in coronary artery disease.
Eichstädt HW; Eskötter H; Hoffman I; Amthauer HW; Weidinger G
Am J Cardiol; 1995 Jul; 76(2):122A-125A. PubMed ID: 7604786
[TBL] [Abstract][Full Text] [Related]
18. Immediate effect of fluvastatin on lipid levels in acute coronary syndrome.
Ostadal P; Alan D; Vejvoda J; Cepova J; Kukacka J; Blasko P; Martinkovicova L; Vojacek J
Mol Cell Biochem; 2007 Dec; 306(1-2):19-23. PubMed ID: 17653509
[TBL] [Abstract][Full Text] [Related]
19. Fluvastatin alters platelet aggregability in patients with hypercholesterolemia: possible improvement of intraplatelet redox imbalance via HMG-CoA reductase.
Haramaki N; Ikeda H; Takenaka K; Katoh A; Sugano R; Yamagishi S; Matsuoka H; Imaizumi T
Arterioscler Thromb Vasc Biol; 2007 Jun; 27(6):1471-7. PubMed ID: 17379842
[TBL] [Abstract][Full Text] [Related]
20. LDL-receptor gene mutations and the hypocholesterolemic response to statin therapy.
Brorholt-Petersen JU; Jensen HK; Raungaard B; Gregersen N; Faergeman O
Clin Genet; 2001 Jun; 59(6):397-405. PubMed ID: 11453971
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
